Free Trial

Commerzbank (ETR:CBK) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?

Commerzbank logo with Financial Services background

Commerzbank AG (ETR:CBK - Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of €23.10 ($27.18) and traded as high as €28.63 ($33.68). Commerzbank shares last traded at €28.20 ($33.18), with a volume of 2,541,106 shares.

Commerzbank Stock Performance

The company has a quick ratio of 0.36, a current ratio of 6.76 and a debt-to-equity ratio of 12.97. The stock has a market cap of $35.46 billion, a price-to-earnings ratio of 15.28, a P/E/G ratio of 4.82 and a beta of 1.08. The company has a 50 day simple moving average of €27.56 and a 200 day simple moving average of €23.26.

About Commerzbank

(Get Free Report)

Commerzbank AG provides banking and capital market products and services to private and small business customers, corporate, financial service providers, and institutional clients in Germany, rest of Europe, the Americas, Asia, and internationally. It operates through two segments, Private and Small-Business Customers, and Corporate Clients.

Further Reading

Should You Invest $1,000 in Commerzbank Right Now?

Before you consider Commerzbank, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Commerzbank wasn't on the list.

While Commerzbank currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines